Today we’re joined by Daphne Koller, co-Founder and former co-CEO of Coursera and Founder and CEO of Insitro. In our conversation, discuss the current landscape of pharmaceutical drugs and drug discovery, including the current pricing of drugs, and an overview of Insitro’s goal of using ML as a “compass” in drug discovery. We also explore how Insitro functions as a company, their focus on the biology of drug discovery and the landscape of ML techniques being used, Daphne’s thoughts on AutoML, and